CBD extract for treating restless legs syndrome
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether a CBD extract (a compound from cannabis that does not cause a high) can help reduce symptoms of Restless Legs Syndrome (RLS). It is a Phase 2 trial, so the goal is to see if the treatment is safe and works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 79 years old.
- You have been diagnosed with Restless Legs Syndrome (RLS) and have moderate to severe symptoms.
- Your RLS medications have not changed in the last 4 weeks.
- You need to have someone who can drive you to appointments (transportation can be provided).
- You must agree to use contraception if applicable.
- You cannot use cannabis (THC) or have a history of drug or alcohol dependence.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether gentle stretching and strength exercises can help pregnant women with restless leg syndrome—a condition that causes uncomfortable sensations in the legs and disrupts sleep. The goal is to see if these exercises reduce symptoms and improve sleep quality during pregnancy.
This trial tests whether cannabis can help cancer patients manage symptoms like sleep trouble, pain, and mood changes. It's for people who are new to using cannabis for these issues.
This study tests whether cannabis can help people with Restless Legs Syndrome that has not improved with standard treatments. If you have RLS and other treatments haven't worked well, you may be able to join.
This study tests a device that sends mild electrical signals to the spinal cord to see if it can reduce severe restless legs syndrome symptoms when standard medicines haven't helped enough.
This trial tests a new drug (a calcium channel modulator) to see how well it works and how safe it is for people with moderate to severe restless legs syndrome (RLS). It may offer a new treatment option for those with typical or variant RLS.
This study tests a high-CBD cannabis extract (BRC-002) to see if it can help reduce pain and improve health in people with Complex Regional Pain Syndrome (CRPS). Participants will not use opioids or other cannabis during the study.
Hear when a new Restless Leg Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.